Effectiveness and safety of first-generation protease inhibitors in real-world patients with hepatitis C virus genotype 1 infection in Brazil: a multicenter study. Clinics [Internet]. 2017 Jun. 1 [cited 2024 Apr. 28];72(6):378-85. Available from: https://revistas.usp.br/clinics/article/view/134124